Flavoring agents and sweeteners improve taste
Kashif Munir, medical director of the University of Maryland Center for Diabetes and Endocrinology
[2] [3] Similarly, in the SURMOUNT trials for weight management, Zepbound's label reports gastrointestinal events as the most common adverse reactions, with nausea (24-30%), diarrhea (18-23%), vomiting (8-12%), and constipation (11-17%) occurring at somewhat higher rates than in diabetes trials
Also, tirzepatide acted as a full and equipotent GIPR agonist, while its interaction with GLP-1R suggested partial agonism
Boosts Recovery & Sleep Improves deep sleep , tissue repair, and muscle recovery